Mother‐to‐Child Transmission of HIV‐2 Infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF‐CO1
Clinical Infectious Diseases2010Vol. 51(7), pp. 833–843
Citations Over TimeTop 10% of 2010 papers
Marianne Burgard, Carine Jasseron, Sophie Matheron, Florence Damond, Karima Hamrene, Stéphane Blanche, Albert Faye, C Rouzioux, J. Warszawski, Laurent Mandelbrot
Abstract
Care for HIV-2-infected pregnant women rests on expert opinion. The mother-to-child transmission residual rate (0.07%-2.2%) argues for systematic treatment: protease inhibitor-based HAART for women requiring antiretrov
Related Papers
- → Lower Human Immunodeficiency Virus (HIV) Type 2 Viral Load Reflects the Difference in Pathogenicity of HIV‐1 and HIV‐2(1999)240 cited
- → HIV RNA level in early infection is predicted by viral load in the transmission source(2010)70 cited
- → Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure?(2002)42 cited
- → Use of an improved quantitative polymerase chain reaction assay to determine differences in human rhinovirus viral loads in different populations(2012)21 cited
- → Estimation of the Predictive Role of Plasma Viral Load on CD4 Decline in HIV-1 Subtype C-Infected Subjects in India(2009)6 cited